Folgen
Carmen Elena Gomez
Carmen Elena Gomez
CNB
Bestätigte E-Mail-Adresse bei sistemaseg.es - Startseite
Titel
Zitiert von
Zitiert von
Jahr
La investigación científica y las formas de titulación
C Gómez, G Álvarez, A Romero, F Castro, V Vega, R Comas, ...
Aspectos conceptuales y prácticos. Quito: Editorial Jurídica del Ecuador 256, 2017
10192017
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome
J Delaloye, T Roger, QG Steiner-Tardivel, D Le Roy, M Knaup Reymond, ...
PLoS pathogens 5 (6), e1000480, 2009
3742009
Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19
CE Gómez, B Perdiguero, M Esteban
Vaccines 9 (3), 243, 2021
2622021
Malformations of the craniocervical junction (Chiari type I and syringomyelia: classification, diagnosis and treatment)
A Avellaneda Fernandez, A Isla Guerrero, M Izquierdo Martínez, ...
BMC Musculoskeletal disorders 10, 1-11, 2009
2372009
The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer
CE Gómez, JL Nájera, M Krupa, M Esteban
Current gene therapy 8 (2), 97-120, 2008
1882008
Escala sobre la ideología del rol sexual
M Moya, M Navas, C Gómez
Libro de Comunicaciones del III Congreso Nacional de Psicología Social 1 …, 1991
1761991
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
BJ Flynn, K Kastenmüller, U Wille-Reece, GD Tomaras, M Alam, ...
Proceedings of the National Academy of Sciences 108 (17), 7131-7136, 2011
1672011
Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV …
CE Gómez, JL Nájera, EP Jiménez, V Jiménez, R Wagner, M Graf, ...
Vaccine 25 (15), 2863-2885, 2007
1242007
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and …
KM Quinn, A Da Costa, A Yamamoto, D Berry, RWB Lindsay, PA Darrah, ...
The Journal of Immunology 190 (6), 2720-2735, 2013
1232013
Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene
JL Nájera, CE Gómez, E Domingo-Gil, MM Gherardi, M Esteban
Journal of virology 80 (12), 6033-6047, 2006
1162006
Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C
CE Gómez, JL Nájera, V Jiménez, K Bieler, J Wild, L Kostic, S Heidari, ...
Vaccine 25 (11), 1969-1992, 2007
1072007
The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens
CE Gómez, JL Nájera, B Perdiguero, J García-Arriaza, COS Sorzano, ...
Journal of virology 85 (21), 11468-11478, 2011
982011
Differential CD4+ versus CD8+ T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide …
P Mooij, SS Balla-Jhagjhoorsingh, G Koopman, N Beenhakker, ...
Journal of virology 82 (6), 2975-2988, 2008
982008
Poxvirus vectors as HIV/AIDS vaccines in humans
C Elena Gomez, B Perdiguero, J García-Arriaza, M Esteban
Human vaccines & immunotherapeutics 8 (9), 1192-1207, 2012
932012
Improved NYVAC-based vaccine vectors
KV Kibler, CE Gomez, B Perdiguero, S Wong, T Huynh, S Holechek, ...
PloS one 6 (11), e25674, 2011
892011
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1 …
F García, JCLB de Quirós, CE Gómez, B Perdiguero, JL Nájera, ...
Vaccine 29 (46), 8309-8316, 2011
852011
Clinical applications of attenuated MVA poxvirus strain
CE Gómez, B Perdiguero, J García-Arriaza, M Esteban
Expert review of vaccines 12 (12), 1395-1416, 2013
842013
Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic
M Corbett, WM Bogers, JL Heeney, S Gerber, C Genin, A Didierlaurent, ...
Proceedings of the National Academy of Sciences 105 (6), 2046-2051, 2008
842008
Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions
J García-Arriaza, JL Nájera, CE Gómez, COS Sorzano, M Esteban
PLoS One 5 (8), e12395, 2010
822010
A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses
J García-Arriaza, JL Nájera, CE Gómez, N Tewabe, COS Sorzano, ...
PLoS One 6 (8), e24244, 2011
812011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20